These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 38334195)

  • 1. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
    Fonseca CS; Baker SL; Dobyns L; Janabi M; Jagust WJ; Harrison TM
    Alzheimers Dement; 2024 Apr; 20(4):2526-2537. PubMed ID: 38334195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Tau Deposition Reflects Different Pathways of Subsequent Neurodegeneration and Memory Decline in Cognitively Normal Older Adults.
    Chen X; Toueg TN; Harrison TM; Baker SL; Jagust WJ
    Ann Neurol; 2024 Feb; 95(2):249-259. PubMed ID: 37789559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional Tau Effects on Prospective Cognitive Change in Cognitively Normal Older Adults.
    Chen X; Cassady KE; Adams JN; Harrison TM; Baker SL; Jagust WJ
    J Neurosci; 2021 Jan; 41(2):366-375. PubMed ID: 33219003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults.
    Harrison TM; Du R; Klencklen G; Baker SL; Jagust WJ
    Alzheimers Dement; 2021 Jul; 17(7):1085-1096. PubMed ID: 33325068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults.
    Farrell ME; Papp KV; Buckley RF; Jacobs HIL; Schultz AP; Properzi MJ; Vannini P; Hanseeuw BJ; Rentz DM; Johnson KA; Sperling RA
    Neurology; 2022 Apr; 98(15):e1512-e1524. PubMed ID: 35338074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.
    Scott MR; Hampton OL; Buckley RF; Chhatwal JP; Hanseeuw BJ; Jacobs HI; Properzi MJ; Sanchez JS; Johnson KA; Sperling RA; Schultz AP
    Neuroimage; 2020 Oct; 220():116991. PubMed ID: 32512123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal tau accumulation and atrophy in aging and alzheimer disease.
    Harrison TM; La Joie R; Maass A; Baker SL; Swinnerton K; Fenton L; Mellinger TJ; Edwards L; Pham J; Miller BL; Rabinovici GD; Jagust WJ
    Ann Neurol; 2019 Feb; 85(2):229-240. PubMed ID: 30597624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pathologic and Volumetric Biomarker Changes With Cognitive Decline in Clinically Normal Adults.
    Hanseeuw BJ; Jacobs HIL; Schultz AP; Buckley RF; Farrell ME; Guehl NJ; Becker JA; Properzi M; Sanchez JS; Quiroz YT; Vannini P; Sepulcre J; Yang HS; Chhatwal JP; Gatchel J; Marshall GA; Amariglio R; Papp K; Rentz DM; Normandin M; Price JC; Healy BC; El Fakhri G; Sperling RA; Johnson KA
    Neurology; 2023 Dec; 101(24):e2533-e2544. PubMed ID: 37968130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment.
    Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR;
    JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial volume correction in longitudinal tau PET studies: is it really needed?
    Costoya-Sánchez A; Moscoso A; Sobrino T; Ruibal Á; Grothe MJ; Schöll M; Silva-Rodríguez J; Aguiar P;
    Neuroimage; 2024 Apr; 289():120537. PubMed ID: 38367651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.
    Sperling RA; Mormino EC; Schultz AP; Betensky RA; Papp KV; Amariglio RE; Hanseeuw BJ; Buckley R; Chhatwal J; Hedden T; Marshall GA; Quiroz YT; Donovan NJ; Jackson J; Gatchel JR; Rabin JS; Jacobs H; Yang HS; Properzi M; Kirn DR; Rentz DM; Johnson KA
    Ann Neurol; 2019 Feb; 85(2):181-193. PubMed ID: 30549303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.
    Buckley RF; Scott MR; Jacobs HIL; Schultz AP; Properzi MJ; Amariglio RE; Hohman TJ; Mayblyum DV; Rubinstein ZB; Manning L; Hanseeuw BJ; Mormino EC; Rentz DM; Johnson KA; Sperling RA
    Ann Neurol; 2020 Nov; 88(5):921-932. PubMed ID: 32799367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V; Villemagne VL; Bourgeat P; Fripp J; Acosta O; Chetélat G; Zhou L; Martins R; Ellis KA; Masters CL; Ames D; Salvado O; Rowe CC
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
    Adams JN; Maass A; Berron D; Harrison TM; Baker SL; Thomas WP; Stanfill M; Jagust WJ
    J Neurosci; 2021 Apr; 41(17):3917-3931. PubMed ID: 33731446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults.
    Pereira JB; Harrison TM; La Joie R; Baker SL; Jagust WJ
    Eur J Nucl Med Mol Imaging; 2020 Aug; 47(9):2155-2164. PubMed ID: 31915896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.